Financing for the deal would be primarily carried by share sales of listed companies, including healthcare subsidiary Siemens Healthineers, its finance chief Ralf Thomas said in a statement.
Life Sciences presents a software market opportunity and could expand Siemens’ industrial software total addressable market by $11 billion, the statement added.
Last week, the German company closed its second biggest acquisition of engineering software firm Altair for $10.6 billion after selling a $1.5 billion stake in Siemens Healthineers.
“By acquiring Dotmatics, we’re strategically strengthening our position in Life Sciences and creating a world-leading AI-powered PLM software portfolio as part of Siemens Xcelerator,” CEO Roland Busch said.
Siemens said it expects substantial revenue synergies for medium-term revenue of around $100 million per year, accelerating to over $500 million per year in the long term.
Boston, Massachusetts-based Dotmatics is an R&D scientific software company, which is expected to generate more than $300 million in revenue in 2025, with an adjusted EBITDA margin of above 40%.
Content Courtesy – Reuters
